Skip to main content

Study M102

Study name

Chen JJ 2017

Title

Differential urinary metabolites related with the severity of major depressive disorder

Overall design

Here, an integrated analysis of data from our previous studies was performed to identify the differential metabolites in the urine of moderate and severe major depressive disorder (MDD) patients. A dual platform approach (NMR spectroscopy and GC-MS) was used. All the recruited MDD patients in this study were the first-episode drug-naive MDD patients. Patients with HAMD score ranged from 18 to 24 were assigned into moderate MDD group, and patients with HAMD score greater than 24 were assigned into severe MDD group. 59 moderate MDD patients and 82 HCs were recruited. Similarly, 34 severe MDD patients and 41 HCs were recruited. A urinary metabolomics method was applied.

Study Type

Type1;

Data available

Unavailable

Organism

Human;

Categories of depression

Depressive disorder; Depression; Depression;

Criteria for depression

DSM-IV diagnosed MDD, HAMD-17 > 17

Sample size

216

Tissue

Peripheral; Urine; Urine;

Platform

NMR; NMR: Bruker AVANCE II 600 spectrometer (Rheinstetten, Germany);

MS-based; GC-MS: Agilent 7980 GC system with Agilent 5975 mass selective detector (Agilent Technologies Inc., USA);

PMID

28624318

DOI

10.1016/j.bbr.2017.06.012

Citation

Chen JJ, Zhou CJ, Zheng P, et al. Differential urinary metabolites related with the severity of major depressive disorder. Behav Brain Res 2017;332:280-7.

Metabolite

Citric acid;

Myristic acid;

Palmitic acid;

Glycine;

L-Lactic acid;

L-Alanine;

D-Fructose;

Azelaic acid;

Choline;

Oxoglutaric acid;

Indoxyl sulfate;

Hydroxylamine;

Taurine;

Trimethylamine N-oxide;

D-Ribose;

Glycerophosphocholine;

Sucrose;

Sorbitol;

Acetone;

Isobutyric acid;

Formic acid;

Nicotinic acid;

Malonic acid;

p-Hydroxyphenylacetic acid;

3-Hydroxyphenylacetic acid;

N-Methylnicotinamide;

Vanillic acid;

Oxalacetic acid;